Communication Predicts Medication Self-Efficacy in Glaucoma Patients.

Journal Article (Journal Article;Multicenter Study)

PURPOSE: Medication self-efficacy, or patients' confidence that they can perform medication-related behaviors, is associated with better glaucoma medication adherence. Little is known about how to enhance glaucoma patients' medication self-efficacy. Our purpose is to examine whether patient-provider communication increases glaucoma patients' medication self-efficacy. METHODS: During an 8-month cohort study of 279 glaucoma patients and 15 providers, two office visits were videotape-recorded, transcribed, and coded for six patient-provider communication behaviors. A validated scale was used at baseline and 8-month follow-up to assess patients' confidence in overcoming adherence barriers (adherence barriers self-efficacy) and carrying out tasks to use eye drops correctly (eye drop task self-efficacy). We ran two generalized estimating equations to examine whether more frequent patient-provider communication during office visits predicted increased patient adherence barriers self-efficacy and eye drop task self-efficacy at 8-month follow-up. RESULTS: For each additional topic providers educated about, patients reported an average increase of 0.35 in self-efficacy in overcoming adherence barriers (p < 0.001). Patients also reported an average increase of 1.01 points in eye drop task self-efficacy when providers asked about patients' views of glaucoma and its treatment versus not (p < 0.001). Patients who asked more medication questions (p < 0.001) and African-American patients (p < 0.05) reported lower adherence barriers self-efficacy by 0.30 and 2.15 points, respectively. Women had a 0.63 lower eye drop task self-efficacy than men (p < 0.05). CONCLUSIONS: When providers educate glaucoma patients and assess patient views about glaucoma and its treatment, patients report higher medication self-efficacy. Providers should be aware that patients who ask more medication questions may have less confidence in their ability to overcome barriers to adherence.

Full Text

Duke Authors

Cited Authors

  • Carpenter, DM; Blalock, SJ; Sayner, R; Muir, KW; Robin, AL; Hartnett, ME; Giangiacomo, AL; Tudor, GE; Sleath, BL

Published Date

  • July 2016

Published In

Volume / Issue

  • 93 / 7

Start / End Page

  • 731 - 737

PubMed ID

  • 27003815

Pubmed Central ID

  • PMC4915983

Electronic International Standard Serial Number (EISSN)

  • 1538-9235

Digital Object Identifier (DOI)

  • 10.1097/OPX.0000000000000856


  • eng

Conference Location

  • United States